US Stock MarketDetailed Quotes
XTLB XTL Biopharmaceuticals
- 2.520
- -0.040-1.56%
Close Jun 4 16:00 ET
- 2.640
- +0.120+4.76%
Post 16:51 ET
13.73MMarket Cap-81290P/E (TTM)
2.640High2.420Low22.58KVolume2.500Open2.560Pre Close56.48KTurnover0.55%Turnover RatioLossP/E (Static)5.45MShares4.99052wk High5.08P/B10.41MFloat Cap0.75052wk Low--Dividend TTM4.13MShs Float600.000Historical High--Div YieldTTM8.59%Amplitude0.625Historical Low2.501Avg Price1Lot Size
XTL Biopharmaceuticals Key Stats
EPS
According to the latest financial report of XTL Biopharmaceuticals, the latest earnings per share (TTM) for the company is 0.10. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about XTL Biopharmaceuticals's free cash flow? The latest report shows it as -508.00K. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of XTL Biopharmaceuticals shows that the company's current ratio is 11.43, indicating healthy liquidity.
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of XTL Biopharmaceuticals, the quick ratio is 11.16, indicating that the company can meet its short-term debt obligations.
Quarterly
Loading...
ROE
Want to learn more about the financial health of XTL Biopharmaceuticals? The latest ROE figure is 19.70%, indicating that the company has stable profitability.
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of XTL Biopharmaceuticals, the total asset return on investment (ROA) is 18.12%.
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check XTL Biopharmaceuticals's latest financial report to see how their gross margin is doing - currently at 61.95%.
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of XTL Biopharmaceuticals, the net profit margin is 109.29%, which is a good sign for its profitability.
Quarterly
Loading...
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg